Cancer research

Cancer research

Breakthrough in Prostate Cancer Treatment: Combination Therapy Shows Significant Benefits

Researchers at AstraZeneca have made a groundbreaking discovery in the treatment of prostate cancer, revealing that a combination of poly(ADP-ribose) polymerase inhibitors (PARPi) with androgen receptor (AR) pathway inhibitors (ARPi) can significantly improve outcomes for patients with metastatic, castration-resistant prostate cancer. This study, published in NAR Cancer, found that

Cancer research

Breakthrough in Colon Cancer Treatment: Dual PD-1/CTLA-4 Blockade Show Superior Progression-Free Survival

Researchers from the IRCCS Foundation National Cancer Institute in Milan, Italy, have published a study in The Oncologist, a leading oncology journal, highlighting the superiority of dual PD-1/CTLA-4 blockade with nivolumab and ipilimumab in treating metastatic colorectal cancer (mCRC) patients with deficient mismatch repair (dMMR) and/or microsatellite instability-high

Cancer research

Genomic Associations with Brain Metastasis and Progression in Colorectal Cancer Identified

A recent study published in Neuro-Oncology has identified novel genomic associations with brain metastasis and progression in colorectal cancer, offering a potential basis for personalized clinical management. Researchers at Memorial Sloan-Kettering Cancer Center analyzed next-generation sequencing data from patients with colorectal cancer to identify genomic features associated with brain metastasis